News &
Publications

Contacts

Franklin Hoke
Vice President
for Communications
215-728-2700
215-475-2888 (cell phone)
Franklin.Hoke@fccc.edu

Diana Quattrone
Director of Media Relations
215-728-7784
215-815-7828 (cell phone)
Diana.Quattrone@fccc.edu

Communications Staff

 

News

Fox Chase Cancer Center Opens New Clinical Research Unit

PHILADELPHIA (August 2, 2005) -- Fox Chase Cancer Center, designated by the National Cancer Institute as a Comprehensive Cancer Center, announces the opening of the new Clinical Research Unit (CRU), an addition to Fox Chase's West Building, that consolidates most activities involving clinical trials in one area for patient and staff convenience.

The CRU centralizes outpatient investigational trial functions by placing personnel and patients in the same facility, allowing for optimal response both to patient needs and data management requirements.

"Participating in clinical research can be quite demanding, and the easy access and focused services in the new facility take some of the burden off patients during their treatment," says Rosemary Fox, director of infusion room services at Fox Chase. "Plus, it's important to have a geographically collaborative environment where all disciplines involved in clinical research and patient care can interact."

Fox Chase's continuing growth has necessitated physical expansion of the facilities. The need for this addition was indicated by ever-increasing infusion room volume and a desire to accommodate more infusion room patients.

"The CRU's infusion rooms give patients one-on-one relationships with our nurses," explains vice president of ambulatory care Dorothy Riehs. "Patients have more privacy and are more comfortable in these rooms, especially when receiving longer infusions."

The CRU's 9,000-square-foot first floor houses clinical activity while the new 8,000-square-foot protocol management office occupies the second floor. Construction on the addition began in January 2004 and was completed recently. The clinical area was opened in May.

EwingCole, a national firm headquartered in Philadelphia, was the architect, engineer and planner for the new facility. Nason and Cullen, Inc. was the general contractor.


Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

More 2005 News Releases »